发明名称 CRYSTAL OF FUSED HETEROCYCLIC COMPOUND
摘要 <p>The present invention relates to a crystal of 1-ethyl-7-methyl-3-{4-[(3-methyl-3H-imidazo[4,5-b]pyridin-2-yl)oxy]phenyl}-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one useful as a prophylactic or therapeutic agent for schizophrenia and the like, which shows an X-ray powder diffraction pattern having characteristic peaks at interplaner spacings (d) of 13.59 plus or minus 0.2 and 6.76 plus or minus 0.2 Angstroms in powder X-ray diffraction.</p>
申请公布号 TN2013000510(A1) 申请公布日期 2015.03.30
申请号 TN20130000510 申请日期 2013.12.06
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 YAMAMOTO KATSUHIKO
分类号 A61K31/437;A61P25/18;C07D471/04 主分类号 A61K31/437
代理机构 代理人
主权项
地址